HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Veronika Sexl Selected Research

STAT1 Transcription Factor

1/2020STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity.
10/2014STAT1-S727 - the license to kill.
8/2013CDK8-mediated STAT1-S727 phosphorylation restrains NK cell cytotoxicity and tumor surveillance.
12/2011Putting the brakes on mammary tumorigenesis: loss of STAT1 predisposes to intraepithelial neoplasias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Veronika Sexl Research Topics

Disease

68Neoplasms (Cancer)
03/2022 - 06/2003
15Leukemia
12/2021 - 12/2004
12Lymphoma (Lymphomas)
01/2018 - 12/2003
8Breast Neoplasms (Breast Cancer)
10/2021 - 02/2004
8Hematologic Neoplasms (Hematological Malignancy)
05/2021 - 11/2012
7Infections
05/2021 - 01/2012
6Neoplasm Metastasis (Metastasis)
04/2021 - 06/2005
5Melanoma (Melanoma, Malignant)
12/2020 - 06/2005
5Disease Progression
01/2019 - 04/2008
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2018 - 02/2008
5Carcinogenesis
11/2015 - 01/2009
4Hypoxia (Hypoxemia)
01/2022 - 11/2017
4Inflammation (Inflammations)
01/2019 - 10/2013
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2018 - 10/2013
2Philadelphia Chromosome
03/2022 - 01/2015
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2016
2B-Cell Leukemia (Leukemia, B Cell)
01/2018 - 10/2012
2Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 04/2015
2Obesity
07/2017 - 12/2008
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2013 - 08/2013
2Genetic Translocation (Chromosomal Translocation)
11/2013 - 11/2012
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2012 - 11/2007
2Carcinoma (Carcinomatosis)
05/2011 - 02/2004
1Triple Negative Breast Neoplasms
10/2021
1Wounds and Injuries (Trauma)
01/2021
1Reinfection
01/2020
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020
1Multiple Sclerosis
12/2019
1Prostatic Neoplasms (Prostate Cancer)
06/2019
1Cytomegalovirus Infections (Inclusion Disease)
10/2018
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2018

Drug/Important Bio-Agent (IBA)

14Phosphotransferases (Kinase)IBA
03/2022 - 12/2004
11Proteins (Proteins, Gene)FDA Link
03/2022 - 06/2005
10Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2007
7CytokinesIBA
01/2021 - 01/2013
6Pharmaceutical PreparationsIBA
10/2019 - 11/2012
5Protein Isoforms (Isoforms)IBA
01/2021 - 12/2008
5LigandsIBA
01/2020 - 04/2010
5Janus KinasesIBA
01/2019 - 06/2003
4InterferonsIBA
01/2021 - 01/2012
4PerforinIBA
01/2020 - 08/2013
4STAT1 Transcription FactorIBA
01/2020 - 12/2011
4Messenger RNA (mRNA)IBA
01/2013 - 06/2003
4Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2012 - 12/2003
3Oxygen (Dioxygen)IBA
01/2022 - 11/2017
3Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2021 - 01/2018
3Janus Kinase InhibitorsIBA
05/2021 - 01/2016
3Interferon Type IIBA
01/2021 - 10/2012
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2015 - 06/2005
3Oncogene Proteins (Oncogene Protein)IBA
11/2012 - 11/2007
3Imatinib Mesylate (Gleevec)FDA Link
03/2011 - 02/2008
2STAT5 Transcription FactorIBA
12/2021 - 01/2020
2Cyclin-Dependent Kinase 8IBA
10/2021 - 06/2019
2ruxolitinibIBA
05/2021 - 01/2020
2Interferon-gamma (Interferon, gamma)IBA
04/2021 - 06/2003
2Cyclin-Dependent Kinase 6IBA
12/2020 - 01/2018
2Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 10/2013
2Antineoplastic Agents (Antineoplastics)IBA
12/2018 - 11/2012
2Natural Cytotoxicity Triggering Receptor 1IBA
01/2018 - 01/2018
2Fibronectins (Fibronectin)IBA
01/2018 - 01/2018
2Biological ProductsIBA
01/2018 - 04/2008
2Calcibiotic Root Canal SealerIBA
01/2018 - 04/2015
2Interleukin-6 (Interleukin 6)IBA
07/2017 - 01/2013
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
04/2016 - 08/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 08/2013
2TYK2 Kinase (Tyrosine Kinase 2)IBA
11/2015 - 01/2009
2Granzymes (Granzyme)IBA
10/2014 - 08/2013
2CarcinogensIBA
01/2014 - 07/2006
2Anaplastic Lymphoma KinaseIBA
11/2012 - 11/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2011 - 04/2010
2Growth Factor ReceptorsIBA
12/2006 - 02/2004
2ErbB Receptors (EGF Receptor)IBA
12/2006 - 02/2004
1venetoclaxIBA
03/2022
1navitoclaxIBA
03/2022
1AntibodiesIBA
12/2021
1MAP Kinase Kinase Kinase 5IBA
04/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2021
1Cyclin-Dependent Kinase 4IBA
12/2020
1Protein Kinases (Protein Kinase)IBA
11/2020
1Nuclear Pore Complex Proteins (Nucleoporins)IBA
01/2020
1Adenylate KinaseIBA
01/2020
1nuclear pore complex protein 98IBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Lipase (Acid Lipase)FDA Link
01/2020
1Interleukin-2 (IL2)IBA
01/2020
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2020
1Interleukin-18 (Interleukin 18)IBA
01/2020
1Dimethyl FumarateIBA
12/2019
1Biomarkers (Surrogate Marker)IBA
06/2019
1OligodeoxyribonucleotidesIBA
01/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2018
1Janus Kinase 1IBA
01/2018
1Immune Checkpoint InhibitorsIBA
01/2018
1Extracellular Matrix ProteinsIBA
01/2018

Therapy/Procedure

23Therapeutics
10/2021 - 04/2008
6Transplantation
01/2018 - 12/2004
3Immunotherapy
04/2021 - 01/2018
2Drug Therapy (Chemotherapy)
01/2018 - 01/2016
2Heterologous Transplantation (Xenotransplantation)
06/2005 - 06/2005
1Precision Medicine
03/2021